Search Results 101-110 of 18141 for creatine evidence

1. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Previous diagnosis of MM with objective evidence ... Creatinine ≤ 2.0 milligrams per deciliter (mg/dL), with creatinine ... Evidence of progressive MM compared to ...

2. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors - Mayo Clinic

   Functional (evidence of peptide hormones and/or bioactive substances ... Creatinine ≤ 1.5 x upper limit of normal (ULN) OR calculated creatinine clearance ≥ 40 ...

3. Testing Olaparib For One Or Two Years, With Or Without Bevacizumab, To Treat Ovarian Cancer - Mayo Clinic

   ... evidence of progression following completion of ... Creatinine clearance (CrCL) of > 30 mL/min by the ... No current evidence of intra-abdominal ...

4. Hydroxyproline Influence on Oxalate Metabolism - Mayo Clinic

   Metabolic pathways that lead to oxalate are poorly understood, but recent evidence suggests that hydroxyproline may play a role. ... eGFR (by serum creatinine) > ...

5. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT - Mayo Clinic

   - Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min/1.73 m^2 or a serum creatinine ... evidence of dissemination). - Female ...

6. An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer - Mayo Clinic

   Creatinine Clearance (using the Cockcroft-Gault formula): ... Serum creatinine 1.5 x ULN or creatinine ... evidence of undetectable Prostate Specific ...

7. Pazopanib Hydrochloride in Treating Patients with Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma - Mayo Clinic

   Objective evidence of tumor progression ≤ 185 days prior to registration as assessed by: ... Creatinine ≤ 1.5 mg/dL (133 umol/L) or within normal institutional ...

8. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors - Mayo Clinic

   Radiological evidence for progressive disease (measureable or non-measurable) ... Serum creatinine ≤ 1.5 x ULN; Urine protein to creatinine (UPC) ratio ...

9. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

   ... evidence of disease progression of the bone lesion after irradiation). ... Serum creatinine ≤ 1.5 x ULN or creatinine clearance ≥ 35 ml/min using Cockcroft- ...

10. Aurinia Renal Response In Active Lupus With Voclosporin - Mayo Clinic

    -Subjects with evidence of active nephritis, defined as follows: ... Active tuberculosis (TB), or known history of TB/evidence of old TB if not taking prophylaxis ...